Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 9, 2007
- Accepted for publication November 20, 2007
- Published online March 5, 2008.
Article Versions
- previous version (February 20, 2008 - 08:08).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2008 by Society of Nuclear Medicine
Author Information
- Zi-Bo Li,
- Zhanhong Wu,
- Kai Chen,
- Eun Kyoung Ryu and
- Xiaoyuan Chen
- Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Biophysics, and Bio-X Program, Stanford University School of Medicine, Stanford, California
- For correspondence or reprints contact: Xiaoyuan Chen, PhD, Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Biophysics, and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd., P095, Stanford, CA 94305-5484. E-mail: shawchen{at}stanford.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Dual-Targeted Molecular Imaging of Cancer
- Reply: Dual-Integrin {alpha}v{beta}3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer (68Ga-BBN-RGD)
- Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications
- Clinical Translation of a Dual Integrin {alpha}v{beta}3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD
- Bombesin-Targeted PET of Prostate Cancer
- In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots
- Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer
- 18F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors
- Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer
- Integrins in prostate cancer progression